Cipla launches quality-assured Rectal Artesunate Suppositories for severe malaria in young children
Cipla Ltd, a global pharmaceutical company, and Medicines for Malaria Venture (MMV) announce the launch…
Cipla Ltd, a global pharmaceutical company, and Medicines for Malaria Venture (MMV) announce the launch…
A US$100 million initiative to create an innovative paediatric haematology-oncology treatment network in southern and…
Delaying umbilical cord clamping for 180 seconds in high-risk infants effectively reduced anaemia by eight and…
Researchers at Columbia University’s Mailman School of Public Health found that an important explanation for…
Federal scientists have launched another test in human volunteers of a Zika vaccine. This one…
Johnson & Johnson announced the official launch of its global public health strategy at the…